HCW Biologics Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HCW Biologics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • HCW Biologics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.69M, a 27.3% increase year-over-year.
  • HCW Biologics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$37.1M, a 79.9% decline year-over-year.
  • HCW Biologics Inc. annual Operating Income (Loss) for 2023 was -$25.7M, a 70.6% decline from 2022.
  • HCW Biologics Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 12.8% decline from 2021.
  • HCW Biologics Inc. annual Operating Income (Loss) for 2021 was -$13.4M, a 130% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25.7M -$10.6M -70.6% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-15
2022 -$15.1M -$1.71M -12.8% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-15
2021 -$13.4M -$7.54M -130% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$5.82M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.